← Browse by Condition

Medical Condition

head and neck squamous cell carcinoma

Total Trials

20

Recruiting Now

20

Trial Phases

Phase 2, Phase 1, Phase 2, Phase 1

NCT04857164 Phase 2

Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China

NCT06919666 Phase 1, Phase 2

NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

University of Colorado, Denver

NCT06047379 Phase 1, Phase 2

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Neonc Technologies, Inc.

Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis

National Cancer Institute, Nap...

NCT07216105 Phase 1

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Fate Therapeutics

NCT05526924 Phase 1

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

University of Chicago

NCT06789172 Phase 1

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

United States, Austr...

NCT06645808 EARLY_Phase 1

PET-imaging of Two Vartumabs in Patients With Solid Tumors

Var2 Pharmaceuticals

NCT05183048 EARLY_Phase 1

Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma

University of Alabama at Birmi...

NCT06761937 Phase 1

Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients

Erasmus Medical Center

NCT04429542 Phase 1

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

United States, Austr...

Bicara Therapeutics

NCT03476681 Phase 1, Phase 2

Study of NEO-201 in Solid Tumors Expansion Cohorts

Precision Biologics, Inc

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

Medical University of South Ca...

NCT05576974 Phase 2

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

University of Texas Southweste...

NCT06006169 Phase 2

A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Sichuan Baili Pharmaceutical C...

NCT06248996 Phase 3

a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients

Lund University Hospital

NCT04119024 Phase 1

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT05941338 Phase 2

Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC

Sun Yat-Sen Memorial Hospital ...

Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality

Thomas Jefferson University

NCT06980038 Phase 2

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

National Cancer Institute (NCI...